One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach

Abstract
We address one-sided stopping rules for clinical trials, or more generally, drug development programs, from a decision-theoretic point of view. If efficacy resu...

This publication has 2 references indexed in Scilit: